LAPTOP (NEAT44) – The Late Presenter Treatment Optimisation Study
An Open-Label, Multi-Centre, Randomised Study to Investigate Integrase Inhibitor Versus Boosted Protease Inhibitor Antiretroviral Therapy for Patients with Advanced HIV-Disease
SPONSOR: NEAT ID Foundation
Sponsor code: NEAT44
EudraCT: 2018-003481-13
Phase: III
Indication: ART-naïve HIV-1 infected patients
Countries: UK, France, Germany, Belgium, Spain, Italy, Ireland, Ukraine
Status: Actively recruiting